search button

Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer

  • Authors:
    • Xiuli Zhang
    • Jianhui Qu
    • Gang Sun
    • Jing Yang
    • Yunsheng Yang

  • View Affiliations

  • Published online on: May 1, 2010     https://doi.org/10.3892/ol_00000099
  • Pages: 559-563
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

HER2/neu is one of the few identified oncogenes in tumorigenesis. Attention has been focused on the potential effect of HER2/neu mutations in the tyrosine kinase domain on carcinoma-targeted therapy. However, data concerning HER2/neu mutations in Chinese patients with gastric cancer (GC) are limited. This study aimed to detect the expression and somatic mutations of HER2/neu in Chinese patients with GC. Immunohistochemical staining for HER2/neu was performed on 72 formalin-fixed, paraffin-embedded specimens of GC (40 intestinal and 32 diffuse type). The correlation between the overexpression of HER2/neu and clinicopathological parameters was statistically analyzed. Somatic mutations in the tyrosine kinase domain of HER2/neu in the 72 patients were detected by direct sequencing. In the GC group, overexpression of HER2/neu was detected in 13 of the 72 GC patients and in 4 of the 72 adjacent tissues in the non-tumorous group (18.1 vs. 5.6%, P<0.05). Furthermore, the intestinal type of GC exhibited a higher rate of HER2/neu overexpression than the diffuse type (29.7 vs. 5.7%, P<0.05). The rate of HER2/neu overexpression in stage III-IV (TNM stage) GC cases was significantly higher than that in stage I-II (28.2 vs. 6.6%, P<0.05). HER2/neu overexpression correlated with a significantly less favorable patient survival (P=0.046). No somatic mutations in the tyrosine kinase domain of HER2/neu were detected in tumor tissues or the corresponding non-tumorous ones in the specimens obtained from the 72 Chinese GC patients. Results suggest that overexpression of HER2/neu is a frequent molecular event strongly associated with a poor patient prognosis, whereas the incidence of somatic mutations of the HER2/neu kinase domain is more likely a low-frequency event in Chinese GC patients.
View Figures
View References

Related Articles

Journal Cover

May-June 2010
Volume 1 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Qu J, Sun G, Yang J and Yang Y: Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer . Oncol Lett 1: 559-563, 2010
APA
Zhang, X., Qu, J., Sun, G., Yang, J., & Yang, Y. (2010). Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer . Oncology Letters, 1, 559-563. https://doi.org/10.3892/ol_00000099
MLA
Zhang, X., Qu, J., Sun, G., Yang, J., Yang, Y."Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer ". Oncology Letters 1.3 (2010): 559-563.
Chicago
Zhang, X., Qu, J., Sun, G., Yang, J., Yang, Y."Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer ". Oncology Letters 1, no. 3 (2010): 559-563. https://doi.org/10.3892/ol_00000099